Ipilimumab/NivolumabDiabetes and hypophysitis

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1984卷 / 1期

关键词：

D O I：

10.1007/s40278-023-50512-7

中图分类号：

学科分类号：

摘要：

引用

页码：281 / 281

共 50 条

[31] Ipilimumab-induced hypophysitis: early Australian experience
De Sousa, Sunita M. C.
Long, Georgina V.
Tonks, Katherine T.
MEDICAL JOURNAL OF AUSTRALIA, 2014, 201 (04) : 198 - 199
[32] Ipilimumab/nivolumab/pembrolizumabVitiligo and hypophysitis: 7 case reports
Reactions Weekly, 2020, 1795 (1) : 166 - 166
[33] Ipilimumab induced hypophysitis, pathogenesis and review of current literatures
Okiro, J.
McHugh, C. M.
IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S379 - S379
[34] Ipilimumab/nivolumabImmune-mediated hypophysitis: case report
Reactions Weekly, 2021, 1859 (1) : 199 - 199
[35] Ipilimumab/nivolumabHyponatraemia, hypophysitis and adrenal insufficiency: case report
Reactions Weekly, 2022, 1923 (1) : 270 - 270
[36] Ipilimumab/nivolumabHyperthyroidism, hypothyroidism and hypophysitis : 9 case reports
Reactions Weekly, 2017, 1680 (1) : 191 - 191
[37] Ipilimumab-Induced Hypophysitis: MR Imaging Findings
Carpenter, K. J.
Murtagh, R. D.
Lilienfeld, H.
Weber, J.
Murtagh, F. R.
AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (09) : 1751 - 1753
[38] Ipilimumab/nivolumabAutoimmune diabetes, hypophysitis and itching: case report
Reactions Weekly, 2018, 1721 (1) : 161 - 161
[39] Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis
Faje, Alexander
Reynolds, Kerry
Zubiri, Leyre
Lawrence, Donald
Coher, Justine, V
Sullivan, Ryan J.
Nachtigall, Lisa
Tritos, Nicholas
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (03) : 211 - 219
[40] Ipilimumab/nivolumabAggravation of hypophysitis and inflammatory myopathy: 2 case reports
Reactions Weekly, 2020, 1785 (1) : 295 - 295

← 1 2 3 4 5 →